William Canestaro, Managing Director at Washington Research Foundation (WRF Capital). See sector focus and contact routes.
William Canestaro, Managing Director at Washington Research Foundation (WRF Capital), invests primarily in early-stage life-science and biotechnology startups in Washington state, with initial check sizes ranging from $100,000 to $2 million and annual deployment of roughly $5–$10 million. His portfolio includes over 30–40 Washington-based companies, with a notable investment in SEngine Precision Medicine (Series A, $10M in July 2022). Canestaro’s distinctive thesis centers on commercializing technologies from local nonprofit research institutions to generate public benefit, focusing on biotech, health IT, and digital health across seed to Series B stages.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Seattle.
Investors like William Canestaro · Full investor directory · Investor access · Company funding database